Short interest screen · refreshed after the Sep 28, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | IKTInhibikase TherapeuticsHealthcare | $2.05 | −0.49% | 47.5 | 17.8% | −5% | $286.0M |
| 2 | DMACDiaMedica TherapeuticsHealthcare | $8.32 | +4.79% | 36.7 | 22.6% | +2% | $448.7M |
| 3 | SVRASavaraHealthcare | $5.07 | +1.40% | 36.3 | 29.6% | +5% | $1.04B |
| 4 | LXEOLexeo TherapeuticsHealthcare | $3.14 | −5.14% | 33.4 | 28.2% | +1% | $257.8M |
| 5 | HURATuHURA BiosciencesHealthcare | $2.09 | −0.48% | 32.6 | 15.0% | 0% | $133.2M |
| 6 | TLSITriSalus Life SciencesHealthcare | $4.39 | +1.15% | 28.8 | 8.6% | −9% | $270.3M |
| 7 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $38.88 | −0.79% | 27.4 | 2.7% | −16% | $45.35B |
| 8 | AVIRAtea PharmaceuticalsHealthcare | $5.20 | +0.58% | 27.3 | 12.5% | 0% | $417.1M |
| 9 | PRTAProthenaHealthcare | $8.72 | +5.19% | 26.5 | 20.2% | +1% | $447.7M |
| 10 | GALTGalectin TherapeuticsHealthcare | $3.93 | +0.77% | 25.2 | 21.4% | +3% | $396.3M |
| 11 | AVXLAnavex Life SciencesHealthcare | $2.35 | −1.26% | 25.1 | 16.0% | +3% | $217.8M |
| 12 | CCCCC4 TherapeuticsHealthcare | $3.12 | +4.53% | 22.7 | 40.8% | +7% | $383.2M |
| 13 | BCAXBicara TherapeuticsHealthcare | $18.80 | −2.13% | 22.6 | 22.1% | +3% | $1.24B |
| 14 | DERMJourney MedicalHealthcare | $6.43 | +4.72% | 22.5 | 24.3% | −1% | $181.5M |
| 15 | ZBIOZenas BioPharmaHealthcare | $27.55 | +2.23% | 22.4 | 38.1% | +1% | $1.80B |
| 16 | LBRXLB PharmaceuticalsHealthcare | $37.89 | +1.50% | 21.5 | 23.9% | +6% | $1.22B |
| 17 | SPTXSeaport TherapeuticsHealthcare | $19.64 | −8.74% | 20.7 | 16.3% | 0% | $1.05B |
| 18 | IMNMImmunomeHealthcare | $21.68 | +1.26% | 20.6 | 16.1% | +4% | $2.46B |
| 19 | IMRXImmuneeringHealthcare | $4.16 | −2.58% | 20.6 | 27.8% | +5% | $269.1M |
| 20 | NERVMinerva NeurosciencesHealthcare | $3.40 | 0.00% | 20.1 | 6.0% | +15% | $162.3M |
| 21 | RYTMRhythm PharmaceuticalsHealthcare | $98.56 | −0.10% | 20.1 | 16.0% | 0% | $6.79B |
| 22 | BNTCBenitec BiopharmaHealthcare | $10.02 | +4.48% | 20.0 | 10.4% | −1% | $349.5M |
| 23 | GLSIGreenwich LifeSciencesHealthcare | $18.59 | +2.03% | 19.8 | 25.7% | −2% | $272.9M |
| 24 | SLDBSolid BiosciencesHealthcare | $7.28 | −0.14% | 19.6 | 22.4% | +4% | $780.6M |
| 25 | GYREGyre TherapeuticsHealthcare | $7.49 | +1.90% | 19.2 | 10.3% | +1% | $794.2M |
| 26 | ACHCAcadia HealthcareHealthcare | $27.91 | −0.64% | 18.8 | 23.4% | −5% | $2.60B |
| 27 | TSHATaysha Gene TherapiesHealthcare | $4.99 | +6.85% | 18.8 | 20.1% | +10% | $1.63B |
| 28 | TNGXTango TherapeuticsHealthcare | $24.30 | −2.49% | 18.8 | 29.8% | −2% | $4.10B |
| 29 | FDMT4D Molecular TherapeuticsHealthcare | $14.56 | +0.62% | 18.6 | 27.0% | −1% | $804.4M |
| 30 | TGTXTG TherapeuticsHealthcare | $56.19 | −2.16% | 18.5 | 20.5% | 0% | $8.60B |
| 31 | CRMDCorMedixHealthcare | $7.89 | +0.51% | 18.5 | 23.0% | +1% | $615.0M |
| 32 | CRVSCorvus PharmaceuticalsHealthcare | $11.87 | +2.15% | 18.2 | 24.4% | −10% | $998.5M |
| 33 | KODKodiak SciencesHealthcare | $89.92 | +177.96% | 17.9 | 34.2% | −1% | $5.65B |
| 34 | AVBPArriVent BioPharmaHealthcare | $29.30 | +2.99% | 17.7 | 28.0% | +1% | $1.44B |
| 35 | STOKStoke TherapeuticsHealthcare | $25.50 | +2.82% | 17.3 | 22.7% | 0% | $1.65B |
| 36 | IDYAIDEAYA BiosciencesHealthcare | $38.22 | +4.17% | 17.3 | 11.4% | −2% | $3.69B |
| 37 | OVIDOvid TherapeuticsHealthcare | $2.46 | +2.50% | 17.3 | 13.4% | +2% | $480.4M |
| 38 | GLUEMonte Rosa TherapeuticsHealthcare | $11.71 | −0.51% | 17.1 | 39.1% | +7% | $999.0M |
| 39 | CGONCG OncologyHealthcare | $69.61 | +3.66% | 17.0 | 16.4% | −1% | $6.17B |
| 40 | RNACCartesian TherapeuticsHealthcare | $7.21 | −2.70% | 17.0 | 15.0% | 0% | $218.1M |
| 41 | CATXPerspective TherapeuticsHealthcare | $2.50 | −0.79% | 16.9 | 24.0% | −2% | $285.4M |
| 42 | NGNENeurogeneHealthcare | $28.48 | +0.60% | 16.9 | 25.5% | +5% | $569.9M |
| 43 | CERSCerusHealthcare | $2.45 | −6.49% | 16.6 | 9.3% | +2% | $493.7M |
| 44 | CRSPCRISPR Therapeutics AGHealthcare | $54.09 | −0.26% | 16.5 | 23.1% | +2% | $5.23B |
| 45 | NRXPNRX PharmaceuticalsHealthcare | $2.87 | −4.17% | 16.3 | 31.5% | +5% | $124.3M |
| 46 | PGENPrecigenHealthcare | $7.81 | +0.77% | 16.3 | 23.8% | 0% | $2.80B |
| 47 | KYMRKymera TherapeuticsHealthcare | $112.00 | +0.04% | 16.1 | 17.7% | +2% | $9.31B |
| 48 | LFCRLifecore BiomedicalHealthcare | $6.52 | +55.24% | 15.9 | 9.6% | +10% | $246.8M |
| 49 | OLMAOlema PharmaceuticalsHealthcare | $8.61 | −1.60% | 15.9 | 27.8% | +3% | $753.4M |
| 50 | IBRXImmunityBioHealthcare | $8.52 | +0.95% | 15.9 | 31.7% | 0% | $9.03B |
Data guard: 9 stocks withheld — NG (reported short interest is above 100% of float); EGO (reported short interest is above 100% of float); BNS (reported short interest is above 100% of float); AQN (reported short interest is above 100% of float); CAE (reported short interest is above 100% of float); GIL (reported short interest is above 100% of float); EPRX (reported short interest is above 100% of float); MFI (reported short interest is above 100% of float); CHRN (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.